The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $25.25

Today's change-0.03 -0.12%
Updated February 22 11:25 AM EST. Delayed by at least 15 minutes.
 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $25.25

Today's change-0.03 -0.12%
Updated February 22 11:25 AM EST. Delayed by at least 15 minutes.

Boston Scientific Corp down (U.S.)$0.03

Boston Scientific Corp is lower today, dropping (U.S.)$0.03 or 0.12% to (U.S.)$25.25. Shares have lost 0.63% over the last five days, but sit 1.56% below their 52-week high. This security has outperformed the S&P 500 by 24.89% during the last year.

Key company metrics

  • Open(U.S.) $25.28
  • Previous close(U.S.) $25.28
  • High(U.S.) $25.39
  • Low(U.S.) $25.20
  • Bid / Ask(U.S.) $25.25 / (U.S.) $25.26
  • YTD % change+16.74%
  • Volume2,119,578
  • Average volume (10-day)7,367,191
  • Average volume (1-month)8,823,869
  • Average volume (3-month)8,690,553
  • 52-week range(U.S.) $16.82 to (U.S.) $25.65
  • Beta1.08
  • Trailing P/E100.08×
  • P/E 1 year forward20.25×
  • Forward PEG1.62×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.25
Updated February 22 11:25 AM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue2,1912,1052,1261,964
Total other revenue--------
Total revenue2,1912,1052,1261,964
Gross profit1,5661,5191,4941,396
Total cost of revenue625586632568
Total operating expense2,0511,7572,4601,671
Selling / general / administrative841768774711
Research & development256232222210
Depreciation / amortization138136135136
Interest expense (income), net operating--------
Unusual expense (income)1711567727
Other operating expenses, total20202019
Operating income140348-334293
Interest income (expense), net non-operating-58-58-59-59
Gain (loss) on sale of assets--------
Other--------
Income before tax89257-397228
Income after tax124228-207202
Income tax, total-3529-19026
Net income124228-207202
Total adjustments to net income--------
Net income before extra. items124228-207202
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items124228-207202
Inc. avail. to common incl. extra. items124228-207202
Diluted net income124228-207202
Dilution adjustment--------
Diluted weighted average shares1,3811,3611,3571,370
Diluted EPS excluding extraordinary itemsvalue per share0.090.17-0.150.15
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.170.180.170.16